Journal article

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Jane Goodall, Joaquin Mateo, Wei Yuan, Helen Mossop, Nuria Porta, Susana Miranda, Raquel Perez-Lopez, David Dolling, Dan R Robinson, Shahneen Sandhu, Gemma Fowler, Berni Ebbs, Penny Flohr, George Seed, Daniel Nava Rodrigues, Gunther Boysen, Claudia Bertan, Mark Atkin, Matthew Clarke, Mateus Crespo Show all

Cancer Discovery | AMER ASSOC CANCER RESEARCH | Published : 2017

Grants

Awarded by Movember


Awarded by Prostate Cancer Foundation (PCF)


Awarded by Prostate Cancer UK


Awarded by Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant


Awarded by Biomedical Research Centre


Awarded by Cancer Research UK


Awarded by Prostate Cancer Foundation (PCF) Young Investigator Award


Awarded by Prostate Cancer UK-Medical Research Council Fellowship


Awarded by Prostate Cancer UK PhD Studentship


Awarded by Medical Research Council Fellowship


Funding Acknowledgements

We would like to acknowledge funding support from Movember (Movember/PCUKCEO13-2-002); Prostate Cancer Foundation (PCF grant 20131017); Prostate Cancer UK (PCUK PG12-49); a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant (SU2C-AACR-DT0712; PCF grants 20131017 and 20131017-1); Cancer Research UK (Centre Programme grant); Experimental Cancer Medicine Centre grant funding from Cancer Research UK and the Department of Health; and Biomedical Research Centre funding to the Royal Marsden (ECMC CRM064X). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. TOPARP is an investigator-initiated study supported by Cancer Research UK (grants C12540/A12829, C12540/A13230, C1491/A9895, and C1491/A15955) and conducted with support from the Investigator-Sponsored Study Collaboration between AstraZeneca and the National Institute for Health Research Cancer Research Network. J. Mateo was supported by a Prostate Cancer Foundation (PCF) Young Investigator Award (PCF-16-YOUN11) and a Prostate Cancer UK-Medical Research Council Fellowship (MR/M003272/1). S. Sandhu was supported by the Prostate Cancer Foundation of Australia. G. Seed was supported by a Prostate Cancer UK PhD Studentship (TLD-S15-006). A. Sharp was supported by a Medical Research Council Fellowship (MR/M018618/1).